Solara Active Pharma Sciences Ltd Sustainability Profile
Solara Active Pharma Sciences Ltd, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in 2017, the company has quickly established itself as a key provider of high-quality products, catering to both domestic and international markets. With a focus on innovation and sustainability, Solara offers a diverse range of APIs, particularly in the therapeutic areas of anti-infectives, cardiovascular, and central nervous system medications. The company’s commitment to quality and regulatory compliance has earned it a strong market position, with notable achievements in securing approvals from major global regulatory bodies. Solara's strategic operational regions extend across Asia, Europe, and the Americas, reinforcing its status as a trusted partner in the pharmaceutical supply chain.
DitchCarbon Score
How does Solara Active Pharma Sciences Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Solara Active Pharma Sciences Ltd's score of 18 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Solara Active Pharma Sciences Ltd's reported carbon emissions
In 2023, Solara Active Pharma Sciences Ltd reported total carbon emissions of approximately 54,593,000 kg CO2e, comprising 11,168,000 kg CO2e from Scope 1 and 43,425,000 kg CO2e from Scope 2 emissions. The company has committed to achieving net-zero emissions, although specific targets and timelines have not been disclosed. The emissions data for 2022 indicated a total of approximately 60,862,000 kg CO2e, with Scope 1 emissions at 10,169,000 kg CO2e and Scope 2 emissions at 50,693,000 kg CO2e. This reflects a reduction in total emissions from the previous year, showcasing the company's ongoing efforts to lower its carbon footprint. Solara is classified within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in India. The company has made a commitment to the Science Based Targets initiative (SBTi) and is actively working towards its climate commitments. However, no specific reduction targets have been outlined as of the latest reporting. Overall, Solara Active Pharma Sciences Ltd is taking steps towards sustainability and reducing its environmental impact, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 10,169,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 50,693,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Solara Active Pharma Sciences Ltd's Industry?
How Carbon Intensive is Solara Active Pharma Sciences Ltd's Location?
Solara Active Pharma Sciences Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Solara Active Pharma Sciences Ltd has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Iol Chemcials And Pharmaceuticals
Frequently Asked Questions
Common questions about Solara Active Pharma Sciences Ltd's sustainability data and climate commitments